JMD
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wallace, J.
Right arrow Articles by Pihan, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wallace, J.
Right arrow Articles by Pihan, G.
JMD 2005, Vol. 7, No. 1
Copyright © 2005 American Society for Investigative Pathology & Association for Molecular Pathology

Facile, Comprehensive, High-Throughput Genotyping of Human Genital Papillomaviruses Using Spectrally Addressable Liquid Bead Microarrays

Jan Wallace*, Bruce A. Woda* and German Pihan{dagger}

From the Laboratory of Diagnostic Molecular Oncology, * Division of Anatomic Pathology, University of Massachusetts Medical School, Worcester, Massachusetts; and the Laboratory of Diagnostic Molecular Hematology/Oncology, {dagger} Department of Pathology and Laboratory Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts

Human papillomavirus (HPV) is the worldwide cause of carcinoma of the uterine cervix, a cancer that is the second most common neoplasm in women, resulting in nearly 250,000 deaths a year. The magnitude of the risk of cancer after HPV infection, however, is virus type-specific. Over 40 HPV types can infect the genital tract. Comprehensive, high-throughput typing assays for HPV, however, are not currently available. Blending multiplex PCR and multiplex hybridization using spectrally addressable liquid bead microarrays we have developed a high-throughput, fast, single-tube-typing assay capable of simultaneously typing 45 HPV. The overall incidence of HPV in 429 women tested using this new assay was 72.2% for those with squamous intraepithelial lesions, 51.5% for those with atypical squamous cells of undetermined significance and 15.4% for women with normal cytology, respectively. This compared well with the incidence of HPV detected by a parallel non-typing generic high-risk assay. The new assay detected a wide spectrum of HPV types and a high incidence of mixed infections. We believe our assay may find widespread applications in areas requiring virus type-specific information, such as in epidemiological studies, cancer screening programs, monitoring therapeutic interventions, and evaluating the efficacy of HPV vaccine trials.




This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
J.-j. Choi, C. Kim, and H. Park
Peptide Nucleic Acid-Based Array for Detecting and Genotyping Human Papillomaviruses
J. Clin. Microbiol., June 1, 2009; 47(6): 1785 - 1790.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
Q. Feng, S. Cherne, R. L. Winer, A. Balasubramanian, S.-K. Lee, S. E. Hawes, N. B. Kiviat, and L. A. Koutsky
Development and Evaluation of a Liquid Bead Microarray Assay for Genotyping Genital Human Papillomaviruses
J. Clin. Microbiol., March 1, 2009; 47(3): 547 - 553.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
H.-L. Jiang, H.-H. Zhu, L.-F. Zhou, F. Chen, and Z. Chen
Genotyping of human papillomavirus in cervical lesions by L1 consensus PCR and the Luminex xMAP system
J. Med. Microbiol., June 1, 2006; 55(6): 715 - 720.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
M. Schmitt, I. G. Bravo, P. J. F. Snijders, L. Gissmann, M. Pawlita, and T. Waterboer
Bead-Based Multiplex Genotyping of Human Papillomaviruses
J. Clin. Microbiol., February 1, 2006; 44(2): 504 - 512.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Society for Investigative Pathology and the Association for Molecular Pathology.